Cantel Medical Corp. (NYSE:CMN) declared a semiannual dividend on Monday, October 17th. Stockholders of record on Tuesday, January 17th will be given a dividend of 0.07 per share on Tuesday, January 31st. This represents a dividend yield of 0.18%. The ex-dividend date of this dividend is Thursday, January 12th. This is a positive change from Cantel Medical Corp.’s previous semiannual dividend of $0.06.
Cantel Medical Corp. (NYSE:CMN) opened at 75.90 on Tuesday. The stock has a market cap of $3.14 billion, a P/E ratio of 52.78 and a beta of 1.59. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $81.63. The stock has a 50 day moving average price of $77.95 and a 200-day moving average price of $71.30.
Cantel Medical Corp. (NYSE:CMN) last issued its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The firm had revenue of $179 million for the quarter. During the same quarter in the previous year, the business posted $0.39 EPS. Cantel Medical Corp.’s revenue was up 18.3% compared to the same quarter last year. On average, equities analysts expect that Cantel Medical Corp. will post $1.98 earnings per share for the current year.
In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 14,897 shares of the business’s stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $78.76, for a total transaction of $1,173,287.72. Following the transaction, the chairman now owns 3,190,111 shares in the company, valued at $251,253,142.36. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Steven C. Anaya sold 5,500 shares of the business’s stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $77.07, for a total value of $423,885.00. Following the transaction, the chief accounting officer now owns 48,132 shares in the company, valued at approximately $3,709,533.24. The disclosure for this sale can be found here. Company insiders own 15.30% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Jefferies Group LLC boosted its position in shares of Cantel Medical Corp. by 16.8% in the second quarter. Jefferies Group LLC now owns 3,494 shares of the company’s stock worth $240,000 after buying an additional 502 shares in the last quarter. Quadrature Capital Ltd boosted its position in shares of Cantel Medical Corp. by 8.3% in the second quarter. Quadrature Capital Ltd now owns 3,520 shares of the company’s stock worth $242,000 after buying an additional 271 shares in the last quarter. Ingalls & Snyder LLC bought a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $258,000. Advisor Group Inc. bought a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $270,000. Finally, Menta Capital LLC bought a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $351,000. Institutional investors own 81.61% of the company’s stock.
CMN has been the topic of a number of research analyst reports. Benchmark Co. initiated coverage on Cantel Medical Corp. in a report on Monday, August 29th. They issued a “buy” rating and a $83.00 target price on the stock. Needham & Company LLC initiated coverage on Cantel Medical Corp. in a report on Wednesday, August 24th. They issued a “hold” rating on the stock.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.